N/A
Completed N=268
Follow-Up Extension to the Family Study of Binge Eating Disorder
Source: ClinicalTrials.gov NCT00777634 ↗Enrolled (actual)
268
Serious AEs
—
Results posted
May 2012
Primary outcomePrimary: Incidence of Diagnosis of Dyslipidemia — 34; 18 participants
Summary
This study involves a 2.5 and 5 year follow-up interview for individuals who participated in the initial family study of binge eating disorder. The study includes individuals with and without eating disorder as well as their first degree relatives. As part of the study, participants will be interviewed about their current psychiatric and medical symptoms, their blood pressure will be measured, and laboratory specimens will be obtained.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Incidence of Diagnosis of Dyslipidemia |
34; 18 | — |
| PRIMARY Incidence of Diagnosis of Hypertension |
25; 18 | — |
| PRIMARY Incidence of Diagnosis of Type 2 Diabetes |
13; 10 | — |
| PRIMARY Incidence of Diagnosis of Any Metabolic Syndrome Component |
53; 37 | — |
| PRIMARY Incidence of Diagnosis of Two or More Metabolic Syndrome Components |
18; 8 | — |
| PRIMARY Incidence of Diagnosis of Three or More Metabolic Syndrome Components |
1; 1 | — |
Eligibility Criteria
Inclusion Criteria
- Individuals with or without binge eating disorder and their family members who participated in the initial family study of binge eating disorder and agree to be followed up at 2.5 and 5 years.
Exclusion Criteria
- Unwilling or unable to participate in the follow-up study.
Data sourced from ClinicalTrials.gov (NCT00777634). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.